Press Releases from DelveInsight (513 total)
Propionic Acidemia Pipeline Insight 2025: Emerging Gene and Enzyme Therapies Aim …
DelveInsight's "Propionic Acidemia - Pipeline Insight, 2025" provides an in-depth analysis of the evolving therapeutic landscape for Propionic Acidemia (PA), a rare autosomal recessive metabolic…
Non-Cystic Fibrosis Bronchiectasis Pipeline Insight 2025: FDA Approves BRINSUPRI …
In August 2025, the FDA approved Insmed's BRINSUPRI, the first oral therapy for non-cystic fibrosis bronchiectasis (NCFB) in patients aged 12 years and older, marking…
Hypovolemia Pipeline Insight 2025: Next-Gen Volume Expanders, Oxygen Therapeutic …
DelveInsight's "Hypovolemia - Pipeline Insight, 2025" provides a comprehensive overview of the therapeutic innovations aimed at managing this life-threatening condition characterized by rapid loss of…
Abdominal Aortic Aneurysm (AAA) Repair Devices Market to Register a CAGR of 5.70 …
The global abdominal aortic aneurysm (AAA) repair devices market is poised for steady growth through 2032, supported by the rising prevalence of aneurysms among the…
Adult-Onset Still Disease Pipeline Insight 2025: IL-1/IL-6 Blockade, JAK Inhibit …
DelveInsight's "Adult-Onset Still Disease - Pipeline Insight, 2025" provides a detailed overview of the evolving therapeutic landscape for this rare systemic autoinflammatory disorder. Traditionally reliant…
Laparoscopy Devices Market to Witness Robust Growth by 2032, Driven by Rising Mi …
The laparoscopy devices market is expected to grow steadily through 2032, driven by the increasing adoption of minimally invasive surgical procedures across gastrointestinal, gynecological, and…
Endometrial Ablation Devices Market to Witness Significant Growth by 2032, Drive …
The endometrial ablation devices market is projected to grow steadily through 2032, fueled by the increasing prevalence of abnormal uterine bleeding (AUB) and the preference…
Cardiac Arrhythmia Monitoring Devices Market to Register Strong Growth by 2032, …
The cardiac arrhythmia monitoring devices market is expected to grow steadily through 2032, fueled by the increasing prevalence of cardiovascular diseases, atrial fibrillation, and other…
Blood Flow Measurement Devices Market to See Steady Growth Through 2032, Support …
The blood flow measurement devices market is poised for sustained expansion to 2032, driven by the global rise in cardiovascular and peripheral vascular disease, the…
Trauma Fixation Devices Market to Register a CAGR of 6.41% by 2032, Driven by Ri …
The trauma fixation devices market is expected to grow steadily through 2032, fueled by the increasing burden of bone fractures, sports-related injuries, and road traffic…
Nanomedicine Market to Register a CAGR of 11.39% by 2032, Driven by Expanding Ap …
The nanomedicine market is experiencing rapid growth, propelled by the increasing adoption of nanotechnology in drug delivery, diagnostics, regenerative medicine, and theranostics. Rising demand for…
Cardiac Rhythm Management Devices Market to See Robust Growth Through 2032, Fuel …
The cardiac rhythm management (CRM) devices market is poised for steady expansion through 2032, driven by rising prevalence of atrial fibrillation and heart failure, an…
Embolic Protection Devices Market to Grow at a CAGR of 7.58% by 2032, Driven by …
The embolic protection devices market is expected to register steady growth through 2032, propelled by the increasing incidence of cardiovascular diseases, rising adoption of minimally…
Ablation Devices Market to Register a CAGR of 11.65% by 2032, Fueled by Growing …
The ablation devices market is projected to witness robust growth through 2032, driven by the rising prevalence of cancer, cardiovascular disorders, and chronic pain, along…
Ventricular Assist Devices (VAD) Market to Register a CAGR of 8.12% by 2032, Dri …
The ventricular assist devices (VAD) market is set for substantial growth, fueled by the increasing prevalence of advanced heart failure, the growing adoption of mechanical…
Sinus Dilation Devices Market to Register a CAGR of 9.10% by 2032, Driven by Ris …
The sinus dilation devices market is witnessing robust growth, propelled by the increasing prevalence of chronic sinusitis, the rising preference for minimally invasive procedures, and…
Stereotactic Surgery Devices Market to Register a CAGR of 5.37% by 2032, Driven …
The stereotactic surgery devices market is experiencing substantial growth, fueled by the increasing prevalence of neurological disorders such as brain tumors, Parkinson's disease, and epilepsy,…
X-Linked Adrenoleukodystrophy Pipeline Insight 2025: A New Era of Gene Therapy a …
X-Linked Adrenoleukodystrophy (X-ALD) is a rare, inherited metabolic disorder caused by mutations in the ABCD1 gene, leading to the accumulation of very long-chain fatty acids…
Cytokine Release Syndrome Pipeline Insight 2025: Advancing Therapeutics to Manag …
Cytokine Release Syndrome (CRS) is a life-threatening systemic inflammatory response often associated with CAR-T cell therapies and other immunotherapies. It is characterized by a surge…
Biliary Atresia Pipeline Insight 2025: Emerging Regenerative and Anti-Fibrotic T …
Biliary atresia is a rare and life-threatening pediatric liver disease characterized by progressive fibro-obliteration of the bile ducts, leading to cholestasis, fibrosis, and ultimately liver…
Familial Chylomicronemia Syndrome Pipeline Insight 2025: RNA Therapies and Gene …
DelveInsight's "Familial Chylomicronemia Syndrome - Pipeline Insight, 2025" offers a comprehensive overview of the rapidly advancing therapeutic landscape targeting this ultra-rare autosomal recessive disorder, characterized…
High-Grade Glioma Pipeline Insight 2025: Over 150+ Therapies Target Aggressive B …
High-grade gliomas (HGGs), including glioblastoma multiforme (GBM), represent some of the most aggressive and treatment-resistant brain tumors in oncology. Characterized by rapid progression, poor prognosis,…
Renal Tubular Acidosis Pipeline Insight 2025: Advancing Beyond Symptomatic Manag …
DelveInsight's "Renal Tubular Acidosis - Pipeline Insight, 2025" offers a comprehensive evaluation of the evolving treatment landscape for this rare group of disorders marked by…
Hypofibrinogenemia Pipeline Insight 2025: Advancing Recombinant Therapies, Preci …
DelveInsight's "Hypofibrinogenemia - Pipeline Insight, 2025" delivers a detailed overview of the therapeutic innovations shaping the future of this rare bleeding disorder. Hypofibrinogenemia, characterized by…
Follicular Lymphoma Pipeline Insight 2025: Next-Gen Anti-CD20 Therapies, Bispeci …
DelveInsight's "Follicular Lymphoma - Pipeline Insight, 2025" provides a detailed exploration of the evolving therapeutic landscape for this indolent but incurable subtype of non-Hodgkin lymphoma…
Argininosuccinic Aciduria Pipeline Insight 2025: Advancing Gene Therapies, Ammon …
DelveInsight's "Argininosuccinic Aciduria - Pipeline Insight, 2025" delivers an in-depth examination of the evolving therapeutic landscape for this rare, life-threatening urea cycle disorder (UCD). Caused…
Hereditary Transthyretin Amyloidosis (hATTR) Pipeline Insight 2025: Gene Silence …
DelveInsight's "Hereditary Transthyretin Amyloidosis (hATTR) - Pipeline Insight, 2025" provides an in-depth evaluation of the emerging treatment landscape for this progressive, multisystem, and life-threatening condition…
Homozygous Familial Hypercholesterolemia Pipeline Insight 2025: RNA-Based Therap …
DelveInsight's "Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Insight, 2025" offers a deep analysis of the evolving therapeutic landscape for one of the most severe and…
Lamellar Ichthyosis Pipeline Insight 2025: Topical Gene Therapies, Barrier Repai …
DelveInsight's "Lamellar Ichthyosis - Pipeline Insight, 2025" provides an in-depth analysis of the emerging therapeutic landscape for this debilitating autosomal recessive skin disorder. Characterized by…
Anemia in Chronic Kidney Disease Pipeline Insight 2025: HIF-PH Inhibitors, Novel …
DelveInsight's "Anemia in Chronic Kidney Disease (CKD) - Pipeline Insight, 2025" explores the dynamic therapeutic landscape targeting one of the most burdensome comorbidities in CKD.…
Overactive Bladder Pipeline Insight 2025: Next-Gen Neuromodulation, Beta-3 Agoni …
DelveInsight's "Overactive Bladder (OAB) - Pipeline Insight, 2025" evaluates the robust expansion in therapeutic options for this highly prevalent and quality-of-life-impacting condition. Affecting over 30…
Recessive Dystrophic Epidermolysis Bullosa Pipeline Insight 2025: Gene Therapy, …
DelveInsight's "Recessive Dystrophic Epidermolysis Bullosa (RDEB) - Pipeline Insight, 2025" covers the transformative innovation targeting this devastating genetic skin disorder caused by mutations in the…
Refractory Angina Pipeline Insight 2025: Novel Regenerative, Device-Based, and P …
DelveInsight's "Refractory Angina - Pipeline Insight, 2025" highlights a growing and high-need cardiovascular segment. Refractory angina (RA), characterized by persistent chest pain unresponsive to standard…
Vascular Ehlers-Danlos Syndrome Pipeline Insight 2025: Emerging Therapies Target …
DelveInsight's "Vascular Ehlers-Danlos Syndrome (vEDS) - Pipeline Insight, 2025" explores the evolving therapeutic landscape for this rare and life-threatening genetic disorder. vEDS stems from mutations…
Primary Biliary Cholangitis Pipeline Insight 2025: FXR Agonists, PPAR Modulators …
DelveInsight's "Primary Biliary Cholangitis (PBC) - Pipeline Insight, 2025" delves into the promising pipeline addressing this chronic autoimmune liver disease marked by bile duct inflammation,…
Acute Pain Pipeline Insight 2025: 25+ Innovators Advancing Non-Opioid and Multim …
DelveInsight's "Acute Pain - Pipeline Insight, 2025" provides a comprehensive overview of the dynamic and rapidly evolving pipeline targeting acute pain-a condition that affects millions…
Acute Lymphocytic Leukemia Pipeline Insight 2025: 125+ Companies Advancing CAR-T …
DelveInsight's "Acute Lymphocytic Leukemia - Pipeline Insight, 2025" report provides an in-depth view of the rapidly advancing treatment landscape for ALL, a fast-progressing hematological malignancy…
Acute Kidney Injury Pipeline Insight 2025: 30+ Companies Targeting Renal Repair, …
DelveInsight's "Acute Kidney Injury (AKI) - Pipeline Insight, 2025" highlights a promising and evolving therapeutic landscape aimed at addressing the unmet clinical needs in AKI-a…
Acute-on-Chronic Liver Failure Pipeline Insight, 2025: Biopharma Players Target …
DelveInsight's "Acute-on-Chronic Liver Failure - Pipeline Insight, 2025" offers a deep dive into the evolving therapeutic landscape of ACLF, a complex and life-threatening syndrome characterized…
Acute Ischemic Stroke Pipeline Insight 2025: 20+ Companies Advancing Next-Gen Ne …
DelveInsight's "Acute Ischemic Stroke - Pipeline Insight, 2025" offers a comprehensive look into the evolving therapeutic landscape of one of the leading causes of long-term…
Alcoholic Hepatitis Pipeline Insight 2025: Advancing Targeted Immunomodulators a …
DelveInsight's "Alcoholic Hepatitis - Pipeline Insight, 2025" presents a comprehensive analysis of the evolving therapeutic landscape for Alcoholic Hepatitis (AH), a severe and often life-threatening…
Alpha-1 Antitrypsin Deficiency Pipeline Insight 2025: 40+ Companies Advancing Ta …
DelveInsight's "Alpha-1 Antitrypsin Deficiency - Pipeline Insight, 2025" provides a detailed analysis of the emerging therapeutic landscape for Alpha-1 Antitrypsin Deficiency (AATD), a rare, inherited…
Adrenocortical Carcinoma Pipeline Insight 2025: Targeted Therapies and Immuno-On …
DelveInsight's "Adrenocortical Carcinoma - Pipeline Insight, 2025" provides a comprehensive look into the evolving therapeutic pipeline for Adrenocortical Carcinoma (ACC)-a rare, aggressive malignancy originating in…
Cervical Cancer Pipeline Insight 2025: 70+ Emerging Therapies Targeting HPV-Driv …
DelveInsight's "Cervical Cancer - Pipeline Insight, 2025" provides an in-depth assessment of the rapidly evolving therapeutic landscape for cervical cancer, a malignancy predominantly driven by…
Cerebral Adrenoleukodystrophy Pipeline Insight 2025: Gene Therapies Lead a Parad …
DelveInsight's "Cerebral Adrenoleukodystrophy (CALD) - Pipeline Insight, 2025" examines the evolving therapeutic landscape for CALD, the most severe phenotype of X-linked adrenoleukodystrophy (X-ALD), caused by…
Ataxia Telangiectasia Pipeline Insight 2025: Advancing Gene Therapies and DNA Da …
DelveInsight's "Ataxia Telangiectasia - Pipeline Insight, 2025" provides a comprehensive analysis of ongoing global R&D efforts targeting this ultra-rare, inherited neurodegenerative disorder characterized by cerebellar…
Bullous Pemphigoid Pipeline Insight 2025: Advancing Biologic and Immunomodulator …
DelveInsight's "Bullous Pemphigoid - Pipeline Insight, 2025" report delivers an in-depth analysis of the ongoing research and development landscape targeting bullous pemphigoid (BP)-a chronic, autoimmune…
Benign Prostatic Hyperplasia Pipeline Insight 2025: Advancing Therapies Targetin …
DelveInsight's "Benign Prostatic Hyperplasia (BPH) - Pipeline Insight, 2025" provides a comprehensive review of the therapeutic development landscape for one of the most common non-malignant…
Common Warts Pipeline Insight 2025: Rethinking Immuno-Targeted and Topical Appro …
DelveInsight's "Common Warts - Pipeline Insight, 2025" provides a detailed assessment of the evolving treatment landscape for common warts (verruca vulgaris), a skin condition caused…
Choroideremia Pipeline Insight 2025: Advancing Gene Therapies for an Inherited R …
DelveInsight's "Choroideremia - Pipeline Insight, 2025" offers an in-depth analysis of the emerging therapeutic landscape for Choroideremia, a rare X-linked retinal degenerative disorder caused by…
